Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2024)

Armata Pharmaceuticals (ARMP) reported Receivables - Other of $744000.0 for Q4 2024, down 77.88% on a YoY basis from $3.4 million in Q1 2024, and down 66.47% sequentially from $2.2 million in Q3 2024.

Armata Pharmaceuticals (ARMP) Receivables - Other (2022 - 2024) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 3 years of Receivables - Other data on file, last reported at $744000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Receivables - Other fell 77.88% year-over-year to $744000.0; the trailing twelve-month figure through Dec 2024 stood at $744000.0 (down 77.88% YoY), and the FY2024 full-year result was $744000.0, down 77.88% from the prior year.
  • Receivables - Other declined to $744000.0 in Q4 2024, from $2.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $8.6 million in Q2 2023 to a low of $744000.0 in Q4 2024.
  • A 3-year average of $4.1 million and a median of $2.8 million in 2023 frame the typical range for Receivables - Other.
  • Across the five-year window, Receivables - Other tumbled 49.01% in 2023 and sank 91.34% in 2024, its largest moves.
  • Tracing ARMP's Receivables - Other over 3 years: stood at $6.6 million in 2022, then plunged by 49.01% to $3.4 million in 2023, then sank by 77.88% to $744000.0 in 2024.
  • Business Quant data shows ARMP's Receivables - Other at $744000.0 in Q4 2024, $2.2 million in Q3 2024, and $748000.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Armata Pharmaceuticals 191.29 Mn 186.49 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 744,000.00
Dec 31, 2024 744,000.00
Sep 30, 2024 2.22 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 748,000.00
Jun 30, 2024 748,000.00
Mar 31, 2024 1.71 Mn
Mar 31, 2024 1.71 Mn
Dec 31, 2023 3.36 Mn
Dec 31, 2023 3.36 Mn
Sep 30, 2023 8.50 Mn
Sep 30, 2023 8.50 Mn
Jun 30, 2023 8.63 Mn
Jun 30, 2023 8.63 Mn
Dec 31, 2022 6.60 Mn
Dec 31, 2022 6.60 Mn